Similar articles

• A very late stent thrombosis in a patient with diabetes: a call for lifelong dual anti-platelet therapy.

  Pecot CV, Fuller M, Muldowney JA 3rd, Misra S. Pecot CV, et al. Tenn Med. 2009 May;102(5):37-9. Tenn Med. 2009. PMID: 19456028 No abstract available.
• [Treatment of ischemic heart disease with the platelet aggregation inhibitor clopidogrel].

  Helø OH, Madsen JK, Kastrup J. Helø OH, et al. Ugeskr Laeger. 2004 Apr 26;166(18):1659-62. Ugeskr Laeger. 2004. PMID: 15174400 Review. Danish. No abstract available.
• Increased long term rates of stent thrombosis and mortality in patients given clopidogrel as compared to ticlopidine following coronary stent implantation.

  Wolak A, Amit G, Cafri C, Gilutz H, Ilia R, Zahger D. Wolak A, et al. Int J Cardiol. 2005 Sep 1;103(3):293-7. doi: 10.1016/j.ijcard.2004.08.061. Int J Cardiol. 2005. PMID: 16098392
• Combined ticlopidine and aspirin versus aspirin therapy alone after stent implantation.

  Lowe H, Roy P, Baron D. Lowe H, et al. Circulation. 1996 Dec 1;94(11):2993-4. Circulation. 1996. PMID: 8941139 No abstract available.
• An appraisal of dual antiplatelet therapy with clopidogrel and aspirin for prevention of cardiovascular events.

  Terpening C. Terpening C. J Am Board Fam Med. 2009 Jan-Feb;22(1):51-6. doi: 10.3122/jabfm.2009.01.070282. J Am Board Fam Med. 2009. PMID: 19124633 Review.